https://www.selleckchem.com/products/tpi-1.html
Introduction Polycythemia vera is a chronic hematologic malignancy frequently presented with constitutional symptoms and associated with an increased risk of thrombosis, hemorrhage, and progression to myelofibrosis or acute myeloid leukemia. Current treatment strategies reduce thrombohemorrhagic risk by controlling blood counts and inhibiting platelets, but often fail to address disease-related symptoms or biologically modify the disease.Areas covered We review the current paradigm for treating polycythemia vera, highlight areas of unmet
Like
Comment
Share
